Reducing Vulnerabilities in Upstream and Downstream Supply Chains: Makers of specialty biologics, gene therapies, and other personalized medicines are working to identify and reduce potential supply chain risks both upstream and downstream

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2023-06, Vol.35 (6), p.25
Main Author: Shelley, Suzanne
Format: Article
Language:English
Subjects:
Drugs
Gene therapy
Genes
Logistics
Medical offices
Pharmaceutical industry
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1753-7967